Sphingosine kinase 2 (SK2) targeting in the treatment of multiple myeloma: preclinical and phase I studies of opaganib, an SK 2 inhibitor, in multiple myeloma

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kang, Y; Fan, S; Sundaramoorthy, P; Gasparetto, C; Long, G; Garrett, A; Sellars, E; Mcintyre, J; Maines, L; Ben-Yair, VK; Smith, C; Plasse, T

Published Date

  • November 1, 2018

Published In

Volume / Issue

  • 103 /

Start / End Page

  • E124 - E124

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1879-0852

International Standard Serial Number (ISSN)

  • 0959-8049

Conference Name

  • 30th EORTC-NCI-AACR Symposium

Conference Location

  • Dublin, IRELAND

Conference Start Date

  • November 13, 2018

Conference End Date

  • November 16, 2018